The store will not work correctly when cookies are disabled.
N-(3-(2-Aminophenyl)-3-hydroxypropyl)benzimidamide
ID: ALA4850749
PubChem CID: 164612169
Max Phase: Preclinical
Molecular Formula: C16H19N3O
Molecular Weight: 269.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(NCCC(O)c1ccccc1N)c1ccccc1
Standard InChI: InChI=1S/C16H19N3O/c17-14-9-5-4-8-13(14)15(20)10-11-19-16(18)12-6-2-1-3-7-12/h1-9,15,20H,10-11,17H2,(H2,18,19)
Standard InChI Key: OJKRZGJRUOAGPO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
12.1207 -3.3767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1120 -2.5596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8321 -3.7783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4181 -3.7923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7068 -3.3907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0042 -3.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0088 -4.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7242 -5.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3061 -5.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3149 -5.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6122 -6.2757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9009 -5.8742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8922 -5.0570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5948 -4.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0262 -6.2576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8163 -2.1445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8080 -1.3281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0954 -0.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3898 -1.3468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4016 -2.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 1 0
7 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
10 15 1 0
7 9 1 0
4 5 1 0
2 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 2 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.35 | Molecular Weight (Monoisotopic): 269.1528 | AlogP: 2.31 | #Rotatable Bonds: 5 |
Polar Surface Area: 82.13 | Molecular Species: BASE | HBA: 3 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.34 | CX LogP: 1.50 | CX LogD: -0.91 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.38 | Np Likeness Score: -0.09 |
References
1. Arias F, Franco-Montalban F, Romero M, Carrión MD, Camacho ME.. (2021) Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors., 44 [PMID:34218000] [10.1016/j.bmc.2021.116294] |